Markets:

Overview

News

Currencies

International

Treasuries

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

4.200 -0.010 (-0.24%)

Streaming Delayed Price Updated: 9:30 AM EDT, Jul 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Bicycle Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 Next >

La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday ↗

November 30, 2023

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.

Via Benzinga

Topics Stocks

9 Health Care Stocks With Whale Alerts In Today's Session ↗

November 16, 2023

Via Benzinga

Expert Ratings for Bicycle Therapeutics ↗

November 03, 2023

Via Benzinga

Why Shares of Bicycle Therapeutics Were Rising on Monday ↗

September 11, 2023

The company said it is working with the FDA to structure a phase 2/3 trial for its bladder cancer therapy.

Via The Motley Fool

Where Bicycle Therapeutics Stands With Analysts ↗

September 07, 2023

Via Benzinga

Expert Ratings for Bicycle Therapeutics ↗

August 04, 2023

Via Benzinga

Bicycle Therapeutics's Return On Capital Employed Insights ↗

May 17, 2023

Via Benzinga

14 Analysts Have This to Say About Bicycle Therapeutics ↗

May 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023 ↗

September 12, 2023

Via Benzinga

Why Bicycle Therapeutics Stock Raced Ahead Today ↗

July 13, 2023

The company's latest attempt at capital raising seems to be having enviable success.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 13, 2023

Via Benzinga

Recap: Bicycle Therapeutics Q1 Earnings ↗

May 04, 2023

Via Benzinga

Analyst Ratings for Bicycle Therapeutics ↗

April 18, 2023

Via Benzinga

What 8 Analyst Ratings Have To Say About Bicycle Therapeutics ↗

March 01, 2023

Via Benzinga

Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday ↗

July 13, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) gained 18% to...

Via Benzinga

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗

September 07, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022 ↗

August 31, 2022

Upgrades

Via Benzinga

Expert Ratings for Bicycle Therapeutics ↗

August 22, 2022

Within the last quarter, Bicycle Therapeutics (NASDAQ:BCYC) has observed the following analyst ratings:

Via Benzinga

Analyst Ratings for Bicycle Therapeutics ↗

May 23, 2022

Bicycle Therapeutics (NASDAQ:BCYC) has observed the following analyst ratings within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Looking Into Bicycle Therapeutics's Return On Capital Employed ↗

November 23, 2022

Via Benzinga

Recap: Bicycle Therapeutics Q3 Earnings ↗

November 03, 2022

Bicycle Therapeutics (NASDAQ:BCYC) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Looking Into Bicycle Therapeutics's Return On Capital Employed ↗

August 22, 2022

According to data from Benzinga Pro, during Q2, Bicycle Therapeutics's (NASDAQ:BCYC) reported sales totaled $4.38 million. Despite a 2.67% increase in earnings, the company posted a loss of $26.83...

Via Benzinga

Bicycle Therapeutics: Q2 Earnings Insights ↗

August 04, 2022

Bicycle Therapeutics (NASDAQ:BCYC) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022 ↗

July 28, 2022

Via Benzinga

Where Bicycle Therapeutics Stands With Analysts ↗

July 06, 2022

Over the past 3 months, 5 analysts have published their opinion on Bicycle Therapeutics (NASDAQ:BCYC) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 24, 2022

Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of their outstanding shares is at $47.6 million. As per the press...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 06, 2022

Monday's session saw 84 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

Bicycle Therapeutics's Return On Capital Employed Overview ↗

May 27, 2022

Benzinga Pro data, Bicycle Therapeutics (NASDAQ:BCYC) reported Q1 sales of $3.86 million. Earnings fell to a loss of $27.56 million, resulting in a 52.82% decrease from last quarter.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.